Form 4: Theravance Biopharma Executive Rhonda Farnum Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Rhonda Farnum, SVP at Theravance Biopharma, reports disposing of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On May 20, 2024, Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, disposed of 9,268 ordinary shares to satisfy tax obligations.
- The shares were withheld by the issuer at a price of $9.1 per share.
- Following the transaction, Farnum directly owns 339,965 ordinary shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction for tax purposes.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction related to tax obligations. Such filings are common and provide transparency into executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of share disposal transaction. |
| 05/22/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.